Please wait while we take you to your selected region.
AICA Ribonucleotide, also known as AICAR, is a synthetic compound that resembles a naturally occurring substance involved in cellular energy metabolism. It is commonly studied in scientific research because of its relationship with AMP-activated protein kinase (AMPK), an enzyme that helps regulate energy balance inside cells.
AICAR is converted into an active form within cells, where it can influence AMPK-related pathways. These pathways are involved in glucose metabolism, fatty acid oxidation, and cellular energy regulation. Because of these effects, AICA Ribonucleotide has been investigated in studies related to metabolic disorders, cardiovascular health, and exercise physiology.
In laboratory research, AICAR is often used as a tool to explore how cells respond to changes in energy availability. Researchers may examine its effects on glucose uptake, mitochondrial activity, and other metabolic processes. However, findings from laboratory and animal studies do not automatically establish the same effects in humans.
AICA Ribonucleotide is primarily a research compound and is not approved as a general treatment for weight loss, athletic performance, or other medical purposes. Its potential benefits, safety, and long-term effects require further scientific investigation. Proper handling and use should follow applicable laboratory safety guidelines and institutional protocols.